Clinical

Dataset Information

0

Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer

ABSTRACT: To investigate safety and tolerance of dose-escalation of infusional recombinant human endostatin in combination with mFOLFOX6 as initial therapy for patients with metastatic colorectal cancer.

DISEASE(S): Colorectal Neoplasm,Colorectal Neoplasms

PROVIDER: 2103392 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.
| 2276938 | ecrin-mdr-crc
Transcriptomics Transcription profiling of human dermal endothelial cells treated with 200ng/ml human recombinant endostatin for 6h
2007-04-25 | E-RZPD-20 | biostudies-arrayexpress
Transcriptomics Transcription profiling of human dermal enothelial cells treated with 200ng/ml human recombinant endostatin (Pichia Pastoris)
2013-01-30 | E-RZPD-10 | biostudies-arrayexpress
Clinical Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer
| 2749194 | ecrin-mdr-crc
Clinical Early tumor shrinkage of Cetuximab and mFOLFOX6 in RAS-wild type unresectable metastatic colorectal cancer.
| 2630670 | ecrin-mdr-crc
Clinical Prophylactic administration of recombinant human thrombopoietin in the secondary prevention of thrombocytopenia induced by XELOX adjuvant chemotherapy in patients with stage III colorectal cancer
| 2700221 | ecrin-mdr-crc
Transcriptomics Human osteoblast treated with recombinant TGF-beta
2010-09-30 | GSE17843 | GEO
Genomics Biological effects of recombinant S100A8, recombinant S100A9, and recombinant S100A8/S100A9 on human renal tubular epithelial cells (HK-2)
| PRJNA1104534 | ENA
Transcriptomics Biological effects of recombinant S100A8, recombinant S100A9, and recombinant S100A8/S100A9 on human renal tubular epithelial cells (HK-2)
2024-11-06 | GSE265848 | GEO
Transcriptomics Recombinant human thrombomodulin treatment against endotoxemia-induced myocardial injury
2022-09-01 | GSE131437 | GEO